Solis Pharmaceutical Industries Profile
Key Indicators
- Authorised Capital ₹ 2.55 Cr
as on 16-11-2024
- Paid Up Capital ₹ 2.45 Cr
as on 16-11-2024
- Company Age 3 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 9.90 M
as on 16-11-2024
- Revenue 6.93%
(FY 2023)
- Profit -16.81%
(FY 2023)
- Ebitda -4.91%
(FY 2023)
- Net Worth 5.21%
(FY 2023)
- Total Assets 13.97%
(FY 2023)
About Solis Pharmaceutical Industries
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.55 Cr and a paid-up capital of Rs 2.45 Cr.
The company currently has active open charges totaling ₹9.90 M.
Sandhya Vembakkam and Vijay Vembakam serve as directors at the Company.
- CIN/LLPIN
U24299TG2021PTC154809
- Company No.
154809
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Sep 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Solis Pharmaceutical Industries Private Limited offer?
Solis Pharmaceutical Industries Private Limited offers a wide range of products and services, including Organic and Inorganic Solvents, Ketones.
Who are the key members and board of directors at Solis Pharmaceutical Industries?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sandhya Vembakkam  | Director | 09-Sep-2021 | Current |
| Vijay Vembakam | Director | 09-Sep-2021 | Current |
Financial Performance of Solis Pharmaceutical Industries.
Solis Pharmaceutical Industries Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 6.93% increase. The company also saw a substantial fall in profitability, with a 16.81% decrease in profit. The company's net worth moved up by a moderate rise of 5.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Solis Pharmaceutical Industries?
Unlock access to Solis Pharmaceutical Industries's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Starior Pharma Private LimitedActive 5 years 11 months
Sandhya Vembakkam and Vijay Vembakam are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 07 Nov 2022 | ₹9.90 M | Open |
How Many Employees Work at Solis Pharmaceutical Industries?
Solis Pharmaceutical Industries has a workforce of 42 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Solis Pharmaceutical Industries, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Solis Pharmaceutical Industries's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
